NKCC1

Class

chloride-importer inhibitor (repurposed diuretic)

NKCC1 (Na-K-Cl cotransporter 1) is a membrane transport protein that moves sodium, potassium, and chloride ions into cells together, using the energy of the sodium gradient established by the sodium-potassium pump. It is expressed broadly, including in neurons, inner-ear tissue, and secretory epithelia, where it helps regulate cell volume and intracellular chloride concentration. In the nervous system, the amount of chloride inside a neuron determines whether the neurotransmitter GABA has an inhibitory (calming) or excitatory effect; NKCC1 activity keeps intracellular chloride relatively high, which is normal early in development but is expected to decline as neurons mature. When this maturation does not proceed normally, GABA signaling can remain excitatory rather than inhibitory, a pattern implicated in certain neurodevelopmental and seizure disorders. Inhibiting NKCC1 lowers intracellular chloride and can restore inhibitory GABA signaling, which is the rationale for repurposing NKCC1-inhibiting diuretics, originally developed for fluid and electrolyte disorders, toward neurological conditions. Because NKCC1 and the related kidney transporter NKCC2 are structurally similar, inhibitors of this class also affect renal salt handling and fluid balance, which is central to their original diuretic use.